Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells

Published:2017-02-17 Issue:3 Volume:11 Page:320-334
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Han Peng¹,Li Hali¹,Jiang Xian¹,Zhai Bo¹²,Tan Gang²,Zhao Dali¹,Qiao Haiquan¹,Liu Bing¹,Jiang Hongchi¹,Sun Xueying¹

Affiliation:

1. The Hepatosplenic Surgery Center; Department of General Surgery; the First Affiliated Hospital of Harbin Medical University; China

2. Department of General Surgery; the Fourth Affiliated Hospital of Harbin Medical University; China

Funder

National Natural Scientific Foundation of China

China Postdoctoral Science Foundation

Scientific Fund for Youths

Postdoctoral Science Foundation

Natural Scientific Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference51 articles.

1. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance;Aksamitiene;Biochem Soc Trans,2012

2. Targeted agents and systemic therapy in hepatocellular carcinoma. Recent results in cancer research. Fortschritte der Krebsforschung;Ang;Progres dans les recherches sur le cancer,2013

3. Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?;Berasain;Gut,2013

4. Targeting the hepatocyte growth factor-cMET axis in cancer therapy;Blumenschein;J Clin Oncol,2012

5. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma;Bruix;Gastroenterology,2016

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical role of miR-21/exosomal miR-21 in autophagy pathway;Pathology - Research and Practice;2024-05

2. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy;MedComm;2024-02

3. Protective role of hesperetin in sorafenib-induced hepato- and neurotoxicity in mice via modulating apoptotic pathways and mitochondrial reprogramming;Life Sciences;2024-01

4. Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma;Frontiers in Pharmacology;2023-04-03

5. Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma;Frontiers in Pharmacology;2023-02-13